Fulminant hepatitis in patients undergoing liver transplantation: Evidence for a non‐A, non‐B, non‐C, non‐D, and non‐E syndrome
M. Lucia Ferraz, A. Eduardo Silva, Graeme A. Macdonald, Sergei A. Tsarev, Adrian M. Di Biscelgie, Michael R. Lucey – 1 January 1996 – Fulminant hepatic failure (FHF) in the absence of serum markers of hepatitis A (HAV) or B (HBV) infection or another cause is called non‐A, non‐B (NANB) FHF. The pathogenetic role of viral infection in NANB FHF remains controversial. To better define this relationship, we studied patients who underwent orthotopic liver transplantation (OLT) for FHF. Thirty‐six patients with FHF underwent transplantation between 1987 and 1992.